Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins.

Haematologica

Volumn 88, Issue 11, 2003, Pages

  Parody, Rocio ^a   Oliver, Arturo ^a   Souto, Juan Carlos ^a   Fontcuberta, Jordi ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; POLYSACCHARIDE;

ACUTE KIDNEY FAILURE; ADENOCARCINOMA; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BLOOD; CASE REPORT; DRUG ERUPTION; DRUG HYPERSENSITIVITY; ENDOMETRIUM TUMOR; FEMALE; HUMAN; INDUCED ABORTION; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE COMPLICATION; PREGNANCY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOPHILIA; THROMBOSIS;

ABORTION, INDUCED; ADENOCARCINOMA; ADULT; AGED; AUTOIMMUNE DISEASES; COMBINED MODALITY THERAPY; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; ENDOMETRIAL NEOPLASMS; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; KIDNEY FAILURE, ACUTE; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYSACCHARIDES; POSTOPERATIVE COMPLICATIONS; PREGNANCY; THROMBOPHILIA; THROMBOSIS;

EID: 1542645757     PISSN: None     EISSN: 15928721     Source Type: Journal    
DOI: None     Document Type: Article

References (0)